Related Experiment Video
Updated: Jan 2, 2026
10:20
Generation of a Human iPSC-Based Blood-Brain Barrier Chip
Published on: March 2, 2020
13.4K
Reusable Standardized Universal Interface Module (RSUIM) for Generic Organ-on-a-Chip Applications
Qiyue Sun1,2,3, Jianghua Pei1,2,3, Qinyu Li1,2,3
1Department of Micro/Nano Electronics, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
Micromachines
|December 11, 2019
Summary
A novel reusable interface module (RSUIM) simplifies organ-on-a-chip system assembly, enabling plug-and-play connections without fluid leakage. This cost-effective design enhances multi-organ system integration for drug screening and biomedical research.
Area of Science:
- Biomedical Engineering
- Microfluidics
- Organ-on-a-Chip Technology
Background:
- Modular organ-on-a-chip systems offer flexible configurations for complex biological mimicry.
- Existing magnetic interconnections are often single-use, increasing manufacturing complexity and cost.
Purpose of the Study:
- To introduce a reusable standardized universal interface module (RSUIM) for organ-on-a-chip applications.
- To enable flexible and cost-effective integration of modular devices into multi-organ systems.
Main Methods:
- Development of pasting-based and clamping-based interconnection modes for the RSUIM.
- Integration of RSUIM with generic vascularized organ-on-a-chip modules.
- Construction of microvascular networks and vascularized tumor models.
- Parallel configuration for high-throughput platform development.
Main Results:
- Demonstrated plug-and-play assembly without fluidic leakage.
- Successful construction and validation of microvascular networks and tumor models.
- Quantitative analysis confirmed reproducibility and anti-cancer drug screening efficacy.
Conclusions:
- The RSUIM provides a versatile, reusable, and cost-effective solution for organ-on-a-chip systems.
- This design facilitates integration into multi-organ systems and high-throughput platforms.
- The RSUIM is poised for commercialization and broad adoption in biomedical research.
